RecruitingPhase 2NCT07186101
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Sponsor: Eli Lilly and Company
Scottsdale, AZ · +39 more sites
Ulcerative Colitis clinical trials in Scottsdale, AZ
9 recruiting ulcerative colitis studies with a site in Scottsdale, AZ.
All trials in Scottsdale, AZ · All Ulcerative Colitis trials
RecruitingPhase 2NCT07415044
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Sponsor: Eli Lilly and Company
Phoenix, AZ · Scottsdale, AZ · +50 more sites
RecruitingPhase 2NCT07483073
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Sponsor: Eli Lilly and Company
Scottsdale, AZ · +13 more sites
RecruitingPhase 1 / Phase 2NCT06619990
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Sponsor: Xencor, Inc.
Scottsdale, AZ · +29 more sites
RecruitingPhase 3NCT07196748
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Sponsor: Janssen Research & Development, LLC
Chandler, AZ · Litchfield Park, AZ · Scottsdale, AZ · +53 more sites
RecruitingPhase 2NCT06636656
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
Sponsor: Boehringer Ingelheim
Scottsdale, AZ · +13 more sites
RecruitingPhase 3NCT07184996
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Sponsor: Sanofi
Peoria, AZ · Scottsdale, AZ · +115 more sites
RecruitingNot applicableNCT05230173
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Sponsor: Mayo Clinic
Scottsdale, AZ · +23 more sites
RecruitingPhase 2NCT07113522
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Sponsor: Mirador Therapeutics, Inc.
Scottsdale, AZ · Sun City, AZ · +44 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.